The dose-dependent regulation of CASP9, along with the downregulation of crucial oncogenes such as COX-2, 5-LOX, Bcl-xL, and Bcl2, positions W. ugandensis as a potential organic inhibitor of CRC tumorigenesis. The gene discussed is BCL2; the disease is colorectal carcinoma.